QSAR analysis on benzodithiazine derivatives as HIV-1 integrase inhibitors

被引:0
作者
Ravichandran, V [2 ]
Jain, A. [1 ]
Mourya, V. K. [3 ]
Agrawal, R. K. [1 ]
机构
[1] Dr Hari Singh Gour Vishwavidyalaya, Dept Pharmaceut Sci, Pharmaceut Chem Res Lab, Sagar 470003, MP, India
[2] AIMST Univ, Fac Pharm, Dept Pharmaceut Chem, Semeling, Kedah, Malaysia
[3] Govt Coll Pharm, Aurangabad, Maharashtra, India
关键词
Human immunodeficiency virus; Integrase; Inhibition; Quantitative Structure Activity Relationship; Benzodithiazines; PREDICTION; PROTEIN; COMFA;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective : Inhibition of HIV-1 integrase is an important strategy for the treatment of HIV and AIDS. Therefore, HIV-1 integrase inhibitory activity of 3-aroyl-1,1-dioxo-1,4,2-benzodithiazines has been analyzed with different physicochemical parameters. Methods : In the present work, quantitative structure activity relationship studies were performed on a series of benzodithiazines as HIV-1. integrase inhibitors using the modeling software Win CAChe version 6.1. Multiple linear regression analysis was performed to derive quantitative structure activity relationship models which were further evaluated for statistical significance and predictive power by internal and external validation. Results : The best QSAR. models were having good correlation coefficient (r) with low Standard error of estimation (SEE) and cross validated square of correlation coefficient (q(2)). The robustness of the models was checked by Y-randomization test and they were identified as good predictive models. The model for HIV integrase (wt) inhibitory activity of benzodithiazines suggest that the increase of dipole moment (Z) of molecules leads to reduce 3' processing and strand transfer inhibitory activity, substitution with high electro positive groups is conducive for the 3' processing inhibitory activity, and the increase in heat of formation is favorable for 3'-processing and strand transfer inhibitory activity. Conclusion The model for HIV integrase (C65s) inhibitory activity of benzodithiazines suggest that the increase of dipole moment (X) of molecules leads to reduce 3' processing and strand transfer inhibitory activity, and the substitution with high hydrophobic groups is conducive for the 3' processing and strand transfer inhibitory.
引用
收藏
页码:15 / 22
页数:8
相关论文
共 28 条
[11]   Computational studies on tetrahydropyrimidine-2-one HIV-1 protease inhibitors: Improving three-dimensional quantitative structure-activity relationship comparative molecular field analysis models by inclusion of calculated inhibitor- and receptor-based properties [J].
Nair, AC ;
Jayatilleke, P ;
Wang, X ;
Miertus, S ;
Welsh, WJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (04) :973-983
[12]   Patented small molecule inhibitors of HIV-1 integrase: a 10-year saga [J].
Neamati, N .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2002, 12 (05) :709-724
[13]   HIV-1 integrase inhibition: Binding sites, structure activity relationships and future perspectives [J].
Parrill, AL .
CURRENT MEDICINAL CHEMISTRY, 2003, 10 (18) :1811-1824
[14]   Three-dimensional quantitative structure-activity relationships study on HIV-1 reverse transcriptase inhibitors in the class of dipyridodiazepinone derivatives, using comparative molecular field analysis [J].
Pungpo, P ;
Hannongbua, S .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2000, 18 (06) :581-+
[15]   3-DIMENSIONAL QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP (QSAR) OF HIV INTEGRASE INHIBITORS - A COMPARATIVE MOLECULAR-FIELD ANALYSIS (COMFA) STUDY [J].
RAGHAVAN, K ;
BUOLAMWINI, JK ;
FESEN, MR ;
POMMIER, Y ;
KOHN, KW ;
WEINSTEIN, JN .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (06) :890-897
[16]  
Ravichandran V, 2008, DIG J NANOMATER BIOS, V3, P19
[17]  
Ravichandran V, 2008, DIG J NANOMATER BIOS, V3, P9
[18]   QSAR study of novel 1,1,3-trioxo[1,2,4]-thiadiazine (TTDs) analogues as potent anti-HIV agents [J].
Ravichandran, V. ;
Mourya, V. K. ;
Agrawala, R. K. .
ARKIVOC, 2007, :204-212
[19]   Predicting anti-HIV activity of PETT derivatives: CoMFA approach [J].
Ravichandran, V. ;
Agrawal, R. K. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (08) :2197-2202
[20]  
Ravichandran V, 2008, INDIAN J PHARM EDUC, V42, P40